LAKE FOREST, Calif.--(BUSINESS WIRE)--I-FLOW CORPORATION (NASDAQ:IFLO) announced today that total revenue from continuing operations for the third quarter of 2008 increased 14% to $32.2 million compared to $28.2 million for the third quarter of 2007. Regional Anesthesia (RA) sales of the Company’s flagship ON-Q® product lines increased 11% for this year’s third quarter to $24.8 million compared to $22.3 million for the third quarter of 2007. Sales of Acute Care products, which include RA sales and AcryMed Incorporated (AcryMed) revenues, increased 18% for this year’s third quarter to $26.3 million compared to $22.3 million for the third quarter a year ago.
